Xiaochun Liu
Overview
Explore the profile of Xiaochun Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
2324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie H, Lu J, Zheng G, Liu X, Chen W
Sci Prog
. 2025 Mar;
108(1):368504251320766.
PMID: 40025902
Objectives: Data regarding the long-term outcomes of patients with thromboangiitis obliterans (TAO) after drug therapy (DT) alone and endovascular procedure (EP)+ drug therapy (DT) are limited. In this study, we...
2.
Guo J, Cai X, Wang S, Wen H, Ren J, Zhou M, et al.
Expert Rev Anti Infect Ther
. 2025 Feb;
:1-9.
PMID: 39994071
Background: High-dose (HD) tigecycline is often required for severe multidrug-resistant gram-negative infections in liver failure patients, despite package recommendations to halve the dose for those with severe liver impairment. This...
3.
Chen W, Liu X
Angiology
. 2025 Feb;
:33197251320145.
PMID: 39968908
Three deficiencies of the Papa criteria (point scoring system, PSS) for thromboangiitis obliterans (TAO) were identified and updated. According to the new criteria, 185 patients with clinically diagnosed TAO in...
4.
Liu K, Deng S, Zhou Y, Xu B, Zhang Y, Li W, et al.
Clin Rev Allergy Immunol
. 2025 Feb;
68(1):16.
PMID: 39954089
The skin surface hosts diverse skin microbiota, including bacteria, fungi, and viruses. Intricate interactions between the skin microenvironment and microbial community are crucial for maintaining cutaneous homeostasis. This review explores...
5.
Ma X, Ma Z, Qi X, Zhang X, Liu X, Liu X, et al.
Bioorg Chem
. 2025 Feb;
156:108185.
PMID: 39947800
The growing concern about drug resistance to KRAS G12C inhibitors emphasizes the urgent need for effective therapies targeting NSCLC with KRAS G12C mutation. In this research, a series of quinazoline-based...
6.
Chen Y, Li Y, Song H, Liu X, Zhang H, Jiang J, et al.
Int J Nanomedicine
. 2025 Feb;
20:1679-1696.
PMID: 39931526
Background: A paramount issue in the realm of chronic wound healing among diabetic patients is the pervasive inflammatory response that persistently thwarts angiogenesis, thereby precipitating protracted delays in the healing...
7.
Zhang N, Zhu X, Tao X, Li J, Tang Q, Liu X, et al.
Microbiol Spectr
. 2025 Feb;
13(3):e0188624.
PMID: 39898669
Importance: Rhizosphere microorganisms release vital signals that shape microbial communities, with antibiotics at low concentrations acting as intra- and interspecies signals. However, the mechanisms of these signals in coordinating gene...
8.
Qu F, Liu Z, Li X, Jin K, Peng R, Shi H, et al.
Int J Biol Macromol
. 2025 Jan;
292:139277.
PMID: 39743083
Factor associated suicide ligand (FasL) is a multifunctional member of tumor necrosis factor ligand (TNF) superfamily, which exerts vital effects on maintaining homeostasis in the immune system. However, the functions...
9.
Chen S, Yang J, Wang X, Liu X, Li X, Ye Y, et al.
Eur J Med Chem
. 2024 Dec;
284():117193.
PMID: 39740323
Bromodomain-containing protein 4 (BRD4) has been identified as a promising target in drug discovery, and the development of novel specific BRD4 bromodomain inhibitors will benefit anti-inflammatory drug discovery as well...
10.
Ma N, Wang J, Tang H, Wu S, Liu X, Chen K, et al.
Adv Sci (Weinh)
. 2024 Dec;
12(7):e2413365.
PMID: 39721012
Type-I photosensitizers (PSs) are among the most potential candidates for photodynamic therapy (PDT), as their low dependence on oxygen endow them with many advantages for treating hypoxic tumor. However, most...